Triasima Portfolio Management inc. lessened its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 12.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,293 shares of the semiconductor company's stock after selling 3,570 shares during the period. Lam Research comprises 1.5% of Triasima Portfolio Management inc.'s investment portfolio, making the stock its 16th biggest holding. Triasima Portfolio Management inc.'s holdings in Lam Research were worth $10,960,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the company. Norges Bank purchased a new stake in shares of Lam Research during the 4th quarter worth $3,645,427,000. Price T Rowe Associates Inc. MD increased its holdings in Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock valued at $2,344,347,000 after buying an additional 10,666,540 shares during the last quarter. Franklin Resources Inc. raised its stake in Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company's stock valued at $1,730,724,000 after buying an additional 3,671,073 shares in the last quarter. Corient Private Wealth LLC raised its stake in Lam Research by 235.5% in the fourth quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company's stock valued at $890,040,000 after buying an additional 3,649,553 shares in the last quarter. Finally, J. Stern & Co. LLP lifted its holdings in Lam Research by 3,826.9% during the 4th quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company's stock worth $592,176,000 after buying an additional 3,371,283 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.
Lam Research Stock Down 6.3%
LRCX stock opened at $307.17 on Thursday. The company has a market cap of $384.37 billion, a price-to-earnings ratio of 53.33, a price-to-earnings-growth ratio of 1.30 and a beta of 1.84. The company has a fifty day moving average price of $339.57 and a 200 day moving average price of $285.35. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts' consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same period in the previous year, the business posted $1.33 earnings per share. Lam Research's quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the company. BNP Paribas Exane upped their price objective on Lam Research from $250.00 to $260.00 and gave the stock a "neutral" rating in a research report on Thursday, April 23rd. Wells Fargo & Company restated an "overweight" rating and set a $350.00 target price (down from $450.00) on shares of Lam Research in a research note on Thursday, July 30th. Sanford C. Bernstein upped their price target on Lam Research from $325.00 to $340.00 and gave the company an "outperform" rating in a report on Thursday, May 21st. New Street Research upped their price target on Lam Research from $235.00 to $280.00 and gave the company a "neutral" rating in a report on Monday, April 27th. Finally, Oppenheimer reiterated an "outperform" rating and issued a $400.00 price target (up from $330.00) on shares of Lam Research in a research note on Monday, June 15th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $358.47.
Read Our Latest Report on Lam Research
Insider Buying and Selling at Lam Research
In other news, SVP Neil J. Fernandes sold 7,659 shares of the business's stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares of the company's stock, valued at approximately $18,102,312. The trade was a 11.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the transaction, the director owned 199,205 shares in the company, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is currently owned by insiders.
About Lam Research
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Articles
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
